Setmelanotide-mediated MC4R activation improves hypothalamic obesity via CaMKK2/AMPK pathways

Hypothalamic obesity (HO) is a disabling disease caused by central nervous system (CNS) damage due to neurosurgery, trauma, or tumors, especially in hypothalamus. The pathological mechanism of its neural circuits is still unclear, and there is currently no corresponding drug due to the complex etiol...

Полное описание

Библиографические подробности

Главные авторы:	Junjie Peng, Yichao Ou, Mingfeng Zhou, Xingqin Wang, Xi’an Zhang, Hao Long, Guangsen Wu, Mengjie Che, Kai Li, Le Yang, Zhu Zhang, Ken Kin Lam Yung, Songtao Qi, Zhanpeng Feng
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-01-01
Серии:	Frontiers in Pharmacology
Предметы:	CaMKK2/AMPK signaling GPCRs hypothalamic obesity melanocortin 4 receptor neuropharmacology setmelanotide
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1730786/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!